Pregled bibliografske jedinice broj: 1030764
Polymyositis with pulmonary and renal involvement refractory to combined immunosuppressive therapy treated with rituximab.
Polymyositis with pulmonary and renal involvement refractory to combined immunosuppressive therapy treated with rituximab. // Clincal and Experimental Rheumatology, 34 (2016), 4; 720-720 (recenziran, članak, znanstveni)
CROSBI ID: 1030764 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Polymyositis with pulmonary and renal involvement refractory to combined immunosuppressive therapy treated with rituximab.
Autori
Barešić , Marko ; Bakula, Marija ; Anić , Branimir
Izvornik
Clincal and Experimental Rheumatology (0392-856X) 34
(2016), 4;
720-720
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Polymyositis
Sažetak
Polymyositis (PM) is a chronic autoimmune disease characterised by symmetrical and bilateral inflammation of proximal muscles. Course of the disease is diverse with symptoms varying from painless muscle weakness to myalgias and constitutional symptoms, but also affection of pharyngeal and respiratory muscles in severe cases (1). Interstitial lung disease (ILD) is found in 60–70% of patients at the time of diagnosis. Pulmonary complications are a major factor causing mortality and a marker of poor prognosis (2)
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE